Cas:4789-11-1 1-p-tolyl-piperidin-2-one manufacturer & supplier

Chemical Name:1-p-tolyl-piperidin-2-one

CAS.NO:4789-11-1

Synonyms:N-p-Tolyl-2-piperidon;1-(4-methyl)phenyl-4-penten-1-one;4-Penten-1-one,1-(4-methylphenyl);1-p-tolyl-pent-4-en-1-one;1-p-Tolylpiperidin-2-on

Molecular Formula:C₁₂H₁₅NO

Molecular Weight:189.25400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:20.31000

Exact Mass:189.11500

LogP:2.57690

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-p-Tolyl-2-piperidon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-p-Tolylpiperidin-2-on physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-p-Tolylpiperidin-2-on Use and application,1-p-Tolylpiperidin-2-on technical grade,usp/ep/jp grade.

Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 1-p-tolyl-piperidin-2-one manufacturer Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 1-p-tolyl-piperidin-2-one supplier China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 1-p-tolyl-piperidin-2-one vendor China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 1-p-tolyl-piperidin-2-one factory The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA.